These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17641000)

  • 1. Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of human erythropoietin.
    Fares F; Ganem S; Hajouj T; Agai E
    Endocrinology; 2007 Oct; 148(10):5081-7. PubMed ID: 17641000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusing the carboxy-terminal peptide of the chorionic gonadotropin (CG) beta-subunit to the common alpha-subunit: retention of O-linked glycosylation and enhanced in vivo bioactivity of chimeric human CG.
    Furuhashi M; Shikone T; Fares FA; Sugahara T; Hsueh AJ; Boime I
    Mol Endocrinol; 1995 Jan; 9(1):54-63. PubMed ID: 7539107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing a long-acting human growth hormone (hGH) by fusing the carboxyl-terminal peptide of human chorionic gonadotropin beta-subunit to the coding sequence of hGH.
    Fares F; Guy R; Bar-Ilan A; Felikman Y; Fima E
    Endocrinology; 2010 Sep; 151(9):4410-7. PubMed ID: 20660071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant thyrotropin containing a beta-subunit chimera with the human chorionic gonadotropin-beta carboxy-terminus is biologically active, with a prolonged plasma half-life: role of carbohydrate in bioactivity and metabolic clearance.
    Joshi L; Murata Y; Wondisford FE; Szkudlinski MW; Desai R; Weintraub BD
    Endocrinology; 1995 Sep; 136(9):3839-48. PubMed ID: 7544273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a Long Acting Erythropoietin by Fusing Three Carboxyl-Terminal Peptides of Human Chorionic Gonadotropin β Subunit to the N-Terminal and C-Terminal Coding Sequence.
    Fares F; Havron A; Fima E
    Int J Cell Biol; 2011; 2011():275063. PubMed ID: 21869890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of in vitro stability and pharmacokinetics of hIFN-α by fusing the carboxyl-terminal peptide of hCG β-subunit.
    Ceaglio N; Gugliotta A; Tardivo MB; Cravero D; Etcheverrigaray M; Kratje R; Oggero M
    J Biotechnol; 2016 Mar; 221():13-24. PubMed ID: 26806490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin beta subunit to the follitropin beta subunit.
    Fares FA; Suganuma N; Nishimori K; LaPolt PS; Hsueh AJ; Boime I
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4304-8. PubMed ID: 1374895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolonged half-lives of new erythropoietin derivatives via peptide addition.
    Lee DE; Son W; Ha BJ; Oh MS; Yoo OJ
    Biochem Biophys Res Commun; 2006 Jan; 339(1):380-5. PubMed ID: 16314154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Processing of O-linked glycosylation in the chimera consisting of alpha-subunit and carboxyl-terminal peptide of the human chorionic gonadotropin beta-subunit is affected by dimer formation with follicle-stimulating hormone beta-subunit.
    Furuhashi M; Suganuma N
    Endocr J; 2004 Feb; 51(1):53-9. PubMed ID: 15004409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the 3' region of mammalian gonadotropin β subunit gene in the luteinizing hormone to chorionic gonadotropin evolution.
    Gabay R; Rozen S; Samokovlisky A; Amor Y; Rosenfeld R; Kohen F; Amsterdam A; Berger P; Ben-Menahem D
    Mol Cell Endocrinol; 2014 Feb; 382(2):781-90. PubMed ID: 24239648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carboxy-terminal region of the beta-subunits of luteinizing hormone and chorionic gonadotropin differentially influence secretion and assembly of the heterodimers.
    Muyan M; Furuhashi M; Sugahara T; Boime I
    Mol Endocrinol; 1996 Dec; 10(12):1678-87. PubMed ID: 8961276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-engineering erythropoietin as an IgG fusion protein that penetrates the blood-brain barrier in the mouse.
    Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
    Mol Pharm; 2010 Dec; 7(6):2148-55. PubMed ID: 20860349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patents on enhancing the potency and longevity of highly valuable protein hormones.
    Fares F; Fima E; Havron A
    Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):148-54. PubMed ID: 23506015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-chain bifunctional vascular endothelial growth factor (VEGF)-follicle-stimulating hormone (FSH)-C-terminal peptide (CTP) is superior to the combination therapy of recombinant VEGF plus FSH-CTP in stimulating angiogenesis during ovarian folliculogenesis.
    Trousdale RK; Pollak SV; Klein J; Lobel L; Funahashi Y; Feirt N; Lustbader JW
    Endocrinology; 2007 Mar; 148(3):1296-305. PubMed ID: 17122074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation-modified erythropoietin with improved half-life and biological activity.
    Su D; Zhao H; Xia H
    Int J Hematol; 2010 Mar; 91(2):238-44. PubMed ID: 20131103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing a small molecule erythropoietin mimetic.
    Guarnieri F
    Methods Mol Biol; 2015; 1289():185-210. PubMed ID: 25709041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietins: a common mechanism of action.
    Elliott S; Pham E; Macdougall IC
    Exp Hematol; 2008 Dec; 36(12):1573-84. PubMed ID: 18922615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides.
    LaPolt PS; Nishimori K; Fares FA; Perlas E; Boime I; Hsueh AJ
    Endocrinology; 1992 Dec; 131(6):2514-20. PubMed ID: 1446593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and characterization of long-acting recombinant human albumin-EPO fusion protein expressed in CHO cell.
    Joung CH; Shin JY; Koo JK; Lim JJ; Wang JS; Lee SJ; Tan HK; Kim SL; Lim SM
    Protein Expr Purif; 2009 Dec; 68(2):137-45. PubMed ID: 19595770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency.
    Fauser BC; Mannaerts BM; Devroey P; Leader A; Boime I; Baird DT
    Hum Reprod Update; 2009; 15(3):309-21. PubMed ID: 19182099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.